SLC2A1 and neoplasm: IHC analyses revealed that the tumor cells were positive for EMA (Fig. 6A) and CD34 (Fig. 6B) and negative for claudin-1, GLUT1, S100 protein, MUC4, STAT6, SMA, HMB45 and P16.